What should be done in emergency situations where consent cannot be obtained prior to trial participation?

• A. Consent should be obtained from the participant or their legally acceptable representative as soon as possible, in accordance with regulatory requirements and IRB/IEC processes.
• B. The trial may proceed without any consent during emergencies.
• C. Consent is never required in emergencies.
• D. Consent should be obtained from a family member only.

Answer: (A)

In emergencies where you can’t obtain consent before enrolling a participant, you must still act with respect for autonomy by getting consent from the participant when they regain capacity or from a legally acceptable representative as soon as feasible, in line with regulatory requirements and the IRB/IEC-approved protocol. This approach recognizes that urgent research may be necessary to address a serious or life-threatening condition, but consent cannot be delayed until after the emergency.

A legally acceptable representative is defined by local law and the study protocol; it could be someone authorized to make healthcare decisions for the participant. You must document why consent wasn’t possible upfront, outline the steps taken to obtain consent later, and comply with any emergency-consent provisions approved by the IRB/IEC. Proceeds without consent or relying solely on a family member, or implying that consent isn’t required in emergencies, are not consistent with GCP.